Why the study?
Does maternal β-blocker exposure increase the risk of fetal cardiac malformations in pregnant women?
Does maternal β-blocker exposure increase the risk of fetal cardiac malformations in pregnant women?
This study investigates the potential teratogenic risk of beta-blockers on fetal cardiac development during pregnancy.
This population-based cohort study examines the risk of fetal cardiac malformations associated with maternal β-blocker exposure.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: